Search results
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 13 hours agoModerna (NASDAQ: MRNA) stock soared earlier in the pandemic as the company developed its coronavirus vaccine and the product went on to generate billions...
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 1 day agoModerna (MRNA) doesn't possess the right combination of the two key ingredients for a likely...
Moderna cancer vaccine offers long-term hope in melanoma
Proactive Investors· 13 hours agoCovid vaccine maker Moderna Inc and partner Merck Sharp and Dohme (MSD) have initiated a phase III...
J.W. Cole Advisors Inc. Purchases 174 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 15 hours agoJ.W. Cole Advisors Inc. lifted its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 8.5% during the fourth quarter, according to the company in its most recent 13F filing ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 2 days agoModerna stock is yo-yoing after the company unveiled early-stage test results for its...
Moderna Employees Should Use ChatGPT at Least 20 Times a Day, CEO Says
Gizmodo via Yahoo News· 1 day agoStéphane Bancel, CEO of Moderna at the Fast Company Innovation Festival on September 21, 2023 in New...
Man receives world’s first melanoma vaccine — trial underway
New York Post· 4 hours agoThe Phase 3 trial hopes to recruit 1,100 people. The vaccine, called mRNA-4157 (V940) works...
Cancer jab offers hope of a cure as NHS trials vaccines that 'destroy melanoma'
The US Sun· 12 hours agoTHE world's first personalised mRNA cancer jab for melanoma is being tested in British patients. The...
Moderna stock closes in green after eight sessions of losses (NASDAQ:MRNA)
Seeking Alpha· 4 days agoMaddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) closed in green and snapped an eight-day losing...
Moderna turns to AI to change how its employees work
CIO Dive· 1 day agoModerna is betting big on bespoke artificial intelligence assistants. The biotechnology company on Wednesday said it has expanded a partnership with OpenAI, the buzzy creator ...
